Professional Documents
Culture Documents
Colgate Ratio Analysis Unsolved
Colgate Ratio Analysis Unsolved
Table of Contents
Income Statements
Balance Sheet
Cash Flows
visit - www.wallstreetmojo.com
Colgate-Palmolive Company
www.wallstreetmojo.com
Income Statement (Consolidated)
Sales
Net Profit
Total Leverage
Operating Leverage
Financial Leverage
Dec-09 Dec-10 Dec-11 Dec-12 Dec-13 Dec-14 Dec-15
15,327 15,564 16,734 17,085 17,420 17,277 16,034
6,319 6,360 7,144 7,153 7,219 7,168 6,635
9,008 9,204 9,590 9,932 10,201 10,109 9,399
Check
Dec-07 Dec-08 Dec-09
Assets
Current Assets
Cash and cash equivalents
Receivables
Inventories
Other current assets
Total current assets
Long-term debt
Deferred income taxes
Other liabilities
Total liabilities
Commitments and contingent liabilities
Shareholders' Equity
Preference stock
Common stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Unearned compensation
Treasury stock, at cost
Total Colgate-Palmolive Company
shareholders' equity
Noncontrolling interests
Total shareholders' equity
Total liabilities and shareholders' equity
Solvency Ratios
Current ratio
Quick ratio
Cash ratio
Sales
COGS
Purchases
Turnover Ratios
Receivables turnover
Inventory Turnover
Payables turnover
Days 365
Average receivables collection period
Average inventory processing period
Average payment period
Cash Collection Cycle
Operating Efficiency
Total asset turnover
Net fixed asset turnover
Equity turnover
Operating Profitability
Gross Profit Margin
Operating Profit Margin
Net Profit Margin
Sustainable Growth
Dec-10 Dec-11 Dec-12 Dec-13 Dec-14 Dec-15
48 34 54 13 16 4
561 346 250 895 488 298
1,165 1,244 1,290 1,343 1,231 1,110
272 392 254 239 294 277
1,682 1,700 1,888 1,980 1,917 1,845
3,728 3,716 3,736 4,470 3,946 3,534
- - - -
733 733 1,466 1,466 1,466 1,466
1,132 1,336 818 1,004 1,236 1,438
14,329 15,649 16,953 17,952 18,832 18,861
(2,115) (2,475) (2,621) (2,451) (3,507) (3,950)
(99) (60) (41) (33) (20) (12)
(11,305) (12,808) (14,386) (15,633) (16,862) (18,102)
Investing Activities
Capital expenditures (550) (537) (565) (670) (757) (691)
Sale of property and non-core product lines 42 263 72 15 24 9
Purchases of marketable securities and investments (308) (356) (545) (505) (340) (742)
Proceeds from sale of marketable securities and investments 167 423 147 267 283 599
Proceeds from sale of South Pacific laundry detergent business 0 221
Payment for acquisitions, net of cash acquired - (966) (29) (3) (87) (13)
Reduction in cash due to Venezuela accounting change 0 (75)
Other (9) (40) 55 6 18 7
Net cash used in investing activities (658) (1,213) (865) (890) (859) (685)
Financing Activities
Principal payments on debt (4,719) (4,429) (5,011) (7,554) (8,525) (9,181)
Proceeds from issuance of debt 5,015 5,843 5,452 7,976 8,960 9,602
Revolver
Dividends paid (1,142) (1,203) (1,277) (1,382) (1,446) (1,493)
Purchases of treasury shares (2,020) (1,806) (1,943) (1,521) (1,530) (1,551)
Proceeds from exercise of stock options and excess tax benefits 242 353 478 339 371 347
Net cash used in financing activities (2,624) (1,242) (2,301) (2,142) (2,170) (2,276)
Effect of exchange rate changes on Cash and cash equivalents (39) (53) (24) (94) (142) (107)
Net increase (decrease) in Cash and cash equivalents (110) 388 6 78 127 (119)
Cash and cash equivalents at beginning of year 600 490 878 884 962 1089
Cash and cash equivalents at end of year $ 490 $ 878 $ 884 $ 962 $ 1,089 $ 970